Nanjing Denovo Pharmaceutical Technology Co., Ltd. is located in the Life Science and Technology Town of Jiangning District, Nanjing. It is a wholly-owned R&D subsidiary of Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd.
Since its establishment in May 2020, the company has been mainly engaged in the preclinical research and development of first-in-class anti-infection and anti-tumor peptide drugs and chemical drugs.The company currently has a strong R&D team mainly composed of doctors and masters, with advanced experimental conditions and equipment.
The company adheres to the spirit of applying what has been learned and overcoming difficulties, adheres to the purpose of developing innovative drugs that meet major clinical needs, and sticks to the field of innovative drug research. The company establishes a rigorous and realistic enterprise image and shows the appearance of a pharmaceutical technology enterprise with great business vitality and development prospects.